What is Incremedical?
Incremedical operates at the intersection of advanced analytics and clinical coordination, providing a robust suite of solutions designed to bridge the gap between healthcare systems, physicians, and post-acute care providers. By leveraging longitudinal care management and data-driven insights, the company enables stakeholders to optimize both clinical outcomes and financial performance. Their platform is engineered to address the systemic inefficiencies inherent in modern care delivery, offering tools that facilitate seamless communication and resource allocation across diverse provider networks. As a key player in the health IT sector, Incremedical serves a broad spectrum of clients, including health plans and employers, by focusing on the reduction of operational costs and the enhancement of patient satisfaction through improved care coordination models.
How much funding has Incremedical raised?
Incremedical has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Incremedical
PPP
Public-Private Partnership
What's next for Incremedical?
With the recent influx of capital, Incremedical is poised to transition into a more aggressive phase of market expansion and product development. The strategic focus will likely center on deepening the integration of its analytics engine to support value-based care initiatives, which are increasingly critical for enterprise-level healthcare providers. By scaling its infrastructure, the company aims to solidify its market position as a leader in post-acute care optimization. Future growth will likely involve expanding its footprint among large-scale health systems that require high-fidelity data to manage complex patient populations effectively. The firm is expected to prioritize the enhancement of its longitudinal care management capabilities, ensuring that its technological offerings remain at the forefront of the evolving digital health landscape.
See full Incremedical company page
